AU2007306171B2 - Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil - Google Patents

Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil Download PDF

Info

Publication number
AU2007306171B2
AU2007306171B2 AU2007306171A AU2007306171A AU2007306171B2 AU 2007306171 B2 AU2007306171 B2 AU 2007306171B2 AU 2007306171 A AU2007306171 A AU 2007306171A AU 2007306171 A AU2007306171 A AU 2007306171A AU 2007306171 B2 AU2007306171 B2 AU 2007306171B2
Authority
AU
Australia
Prior art keywords
acid
olmesartan medoxomil
formula
process according
alkali metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007306171A
Other languages
English (en)
Other versions
AU2007306171A1 (en
Inventor
Rajendra Narayanrao Kankan
Srinivas Laxminarayan Pathi
Ravikumar Puppala
Dharmaraj Ramachandra Rao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cipla Ltd
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of AU2007306171A1 publication Critical patent/AU2007306171A1/en
Application granted granted Critical
Publication of AU2007306171B2 publication Critical patent/AU2007306171B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AU2007306171A 2006-10-09 2007-10-09 Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil Ceased AU2007306171B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1663/MUM/2006 2006-10-09
IN1663MU2006 2006-10-09
PCT/GB2007/003821 WO2008043996A2 (en) 2006-10-09 2007-10-09 Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil

Publications (2)

Publication Number Publication Date
AU2007306171A1 AU2007306171A1 (en) 2008-04-17
AU2007306171B2 true AU2007306171B2 (en) 2013-02-21

Family

ID=39149309

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007306171A Ceased AU2007306171B2 (en) 2006-10-09 2007-10-09 Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil

Country Status (8)

Country Link
US (1) US8076492B2 (enExample)
EP (1) EP2074116A2 (enExample)
JP (1) JP5269798B2 (enExample)
KR (1) KR101458369B1 (enExample)
AU (1) AU2007306171B2 (enExample)
CA (1) CA2663981C (enExample)
NZ (1) NZ575780A (enExample)
WO (1) WO2008043996A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8076492B2 (en) 2006-10-09 2011-12-13 Cipla Limited Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil
EP2036904A1 (en) * 2007-08-08 2009-03-18 LEK Pharmaceuticals D.D. A process for the preparation of olmesartan medoxomil
CA2707365A1 (en) * 2007-08-08 2009-02-12 Lek Pharmaceuticals D.D. A process for the preparation of olmesartan medoxomil
KR101630885B1 (ko) 2008-06-09 2016-06-15 다이이찌 산쿄 가부시키가이샤 1-비페닐메틸이미다졸 화합물의 제조 방법
JP5305421B2 (ja) 2008-12-17 2013-10-02 第一三共株式会社 ジアミン誘導体の製造方法
ES2542236T3 (es) 2009-03-10 2015-08-03 Daiichi Sankyo Company, Limited Procedimiento de producción de un derivado de diamina
CA2760031C (en) * 2009-04-28 2015-03-10 Daiichi Sankyo Company, Limited Acetone solvate crystals of trityl olmesartan medoxomil
ES2527686T3 (es) * 2009-04-28 2015-01-28 Daiichi Sankyo Company, Limited Procedimiento de producción de olmesartán medoxomil
WO2010134052A1 (en) 2009-05-20 2010-11-25 Ranbaxy Laboratories Limited Process for the preparation of olmesartan medoxomil
WO2011007368A2 (en) 2009-07-14 2011-01-20 Cadila Healthcare Limited An improved process for preparation of olmesartan
WO2011021224A2 (en) * 2009-08-19 2011-02-24 Msn Laboratories Limited Process for (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl4-(1-hydroxy-1-methylethyl)-2-propyl-1-[4-[2-tetrazol-5-yl)phenyl]phenyl]methylimidazole-5-carboxylate
KR101257272B1 (ko) * 2010-01-15 2013-04-23 종근당바이오 주식회사 탈보호화 반응을 이용한 고혈압 치료용 비페닐테트라졸 화합물의 제조방법
KR101628758B1 (ko) * 2010-03-31 2016-06-09 주식회사 씨티씨바이오 올메사탄 실렉세틸의 제조 방법
US20130190506A1 (en) * 2010-06-28 2013-07-25 Hetero Research Foundation Process for olmesartan medoxomil
CZ2010785A3 (cs) * 2010-10-29 2012-05-16 Zentiva, K.S. Zpusob výroby olmesartanu medoxomilu
AR083523A1 (es) 2010-10-29 2013-03-06 Interquim Sa Procedimiento de obtencion del olmesartan medoxomilo
KR101696851B1 (ko) * 2010-12-21 2017-01-17 대봉엘에스 주식회사 올메사탄 메독소밀의 유연물질의 제조방법
EP2739619B1 (en) * 2011-08-05 2015-09-16 Lupin Limited Process for the preparation of olmesartan medoxomil
CN103304550B (zh) * 2012-03-16 2016-01-27 湖南欧亚生物有限公司 一种奥美沙坦酯的制备方法
US9624181B2 (en) 2012-08-31 2017-04-18 Api Corporation Method for producing biaryl compound
IN2015DN02241A (enExample) * 2012-09-26 2015-08-21 Api Corp
KR101526249B1 (ko) * 2013-11-14 2015-06-10 동방에프티엘(주) 올메사탄 메독소밀 유도체의 개선된 제조방법
CN104592213A (zh) * 2014-12-15 2015-05-06 山东新华制药股份有限公司 奥美沙坦酯中间体的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
US5310929A (en) * 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
CN1271068C (zh) * 2003-03-25 2006-08-23 上海医药工业研究院 一种奥美沙坦酯的制备方法
EA014026B1 (ru) * 2005-07-29 2010-08-30 Крка, Товарна Здравил, Д.Д., Ново Место Способ получения олмесартан медоксомила
US8076492B2 (en) 2006-10-09 2011-12-13 Cipla Limited Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YU, X.-H. et al., Journal of East China University of Science and Technology, 2005, Vol. 31, No. 2, pages 189-192 *

Also Published As

Publication number Publication date
EP2074116A2 (en) 2009-07-01
NZ575780A (en) 2011-09-30
KR20090080516A (ko) 2009-07-24
KR101458369B1 (ko) 2014-11-05
US8076492B2 (en) 2011-12-13
WO2008043996A2 (en) 2008-04-17
WO2008043996A3 (en) 2008-10-02
JP2010505926A (ja) 2010-02-25
CA2663981C (en) 2014-05-27
AU2007306171A1 (en) 2008-04-17
JP5269798B2 (ja) 2013-08-21
CA2663981A1 (en) 2008-04-17
US20100160643A1 (en) 2010-06-24

Similar Documents

Publication Publication Date Title
AU2007306171B2 (en) Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil
US7923567B2 (en) Process for preparing valsartan
US20090281327A1 (en) Process for the preparation of olmesartan medoxomil
US8501962B2 (en) Process for the preparation of high purity sunitinib and its pharmaceutically acceptable salt
WO2005051943A1 (en) Processes for the preparation of highly pure irbesartan
WO2011007368A2 (en) An improved process for preparation of olmesartan
US7964737B2 (en) Process for producing 2-(n-butyl)-3-[[2′-(tetrazol-5-yl)biphenyl-4-yl]methyl]-1,3-diazaspiro[4.4] non-1-en-4-one
KR101250820B1 (ko) 개선된 로사르탄 제조 방법
WO2009116089A2 (en) Novel intermediates and method for synthesis of 4'-[(1,4'-dimethyl-2'-propyl-[2,6'- bi-1hbenzimidazol]-l-yl)methyl]-1,1-biphenyl]-2-carboxylic acid.
US7741492B2 (en) Method for obtaining a pharmaceutically active compound (Irbesartan) and its synthesis intermediate
US7943780B2 (en) Process for the preparation of candesartan cilexetil
US9499491B2 (en) One pot process for the preparation of telmisartan
US20070249839A1 (en) Process for the Preparation of Losartan Potassium Form I
WO2005037823A1 (en) Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazole-1-yl)methyl]-4h-carbazol-4-one or its salt
KR100856133B1 (ko) 아토르바스타틴의 개선된 제조방법
MX2007007303A (es) Proceso para preparar olmesartan medoxomil a ph superior a 2,5.
KR101266224B1 (ko) 트리틸 올메사르탄 메독소밀의 개선된 제조방법
HK1010539A1 (en) Method for the synthesis of a benzimidazole compound
HK1010539B (en) Method for the synthesis of a benzimidazole compound

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired